Dipeptidyl Peptidase 4 Inhibitors and Risk of Inflammatory Bowel Disease Among Patients With Type 2 Diabetes: A Meta-analysis of Randomized Controlled Trials.

Published

Journal Article (Letter)

Full Text

Duke Authors

Cited Authors

  • Li, G; Crowley, MJ; Tang, H; Yang, JY; Sandler, RS; Wang, T

Published Date

  • July 2019

Published In

Volume / Issue

  • 42 / 7

Start / End Page

  • e119 - e121

PubMed ID

  • 31221707

Pubmed Central ID

  • 31221707

Electronic International Standard Serial Number (EISSN)

  • 1935-5548

Digital Object Identifier (DOI)

  • 10.2337/dc18-1578

Language

  • eng

Conference Location

  • United States